Article | May 4, 2021

Modified-Release Oral Solid Dosage Technologies

By Holger Shen, Technical Services Manager, Bora Pharmaceuticals

Image for Oral Solid Dose Content Piece

For pharmaceutical product owners, to enhance their patients’ lives is their ultimate goal. Successful technology transfers ensuring product performance and safety before the product goes to market is paramount. For their manufacturing partners - pharmaceutical contract manufacturers – successful technology transfers between clients and ourselves is our ultimate goal. If technology transfers are successful, then product performance in confirmed, supply hiccups are minimized. Technology transfer projects aim for transferring the manufacturing, analytics and packaging, including relevant documentation, knowledge and professional expertise involved in the processes. Quality and safety must remain consistent. Contract manufacturing organizations aim for successful technology transfers while remaining consistent with the safety and quality of their clients' products. In some cases, technology transfers may not always proceed smoothly, especially for the modified-release oral solid dose (OSD) drugs. Modified-release drug products are designed to release drugs in a controlled manner to achieve desired efficacy and safety profiles.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: